Negative Regulation of RIG-I by Tim-3 Promotes H1N1 Infection

References

• Arimoto K, Takahashi H, Hishiki T, Konishi H, Fujita T, Shimotohno K. 2007. Negative regulation of the RIG-I signaling by the ubiquitin ligase RNF125. Proc Natl Acad Sci U S A. 104(18):7500–05.
   PubMed Web of Science ®Google Scholar
• Cao L, Ge X, Gao Y, Herrler G, Ren Y, Ren X, Li G. 2015. Porcine epidemic diarrhea virus inhibits dsRNA-induced interferon-β production in porcine intestinal epithelial cells by blockade of the RIG-I-mediated pathway. Virol J. 12:127.
   PubMed Web of Science ®Google Scholar
• Chen W, Han C, Xie B, Hu X, Yu Q, Shi L, Wang Q, Li D, Wang J, Zheng P, et al. 2013. Induction of Siglec-G by RNA viruses inhibits the innate immune response by promoting RIG-I degradation. Cell. 152(3):467–78.
   PubMed Web of Science ®Google Scholar
• Chiba S, Baghdadi M, Akiba H, Yoshiyama H, Kinoshita I, Dosaka-Akita H, Fujioka Y, Ohba Y, Gorman JV, Colgan JD, et al. 2012. Tumor-Infiltrating DCs suppress nucleic acid-mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1. Nat Immunol. 13(9):832–42.
   PubMed Web of Science ®Google Scholar
• Das M, Zhu C, Kuchroo VK. 2017. Tim-3 and its role in regulating anti-tumor immunity. Immunol Rev. 276(1):97–111.
   PubMed Web of Science ®Google Scholar
• De Sousa Linhares A, Kellner F, Jutz S, Zlabinger GJ, Gabius HJ, Huppa JB, Leitner J, Steinberger P. 2020. TIM-3 and CEACAM1 do not interact in cis and in trans. Eur J Immunol. 50(8):1126–41.
   PubMed Web of Science ®Google Scholar
• Elion DL, Jacobson ME, Hicks DJ, Rahman B, Sanchez V, Gonzales-Ericsson PI, Fedorova O, Pyle AM, Wilson JT, Cook RS. 2018. Therapeutically active RIG-I agonist induces immunogenic tumor cell killing in breast cancers. Cancer Res. 78(21):6183–95.
   PubMed Web of Science ®Google Scholar
• Fitzgerald KA, McWhirter SM, Faia KL, Rowe DC, Latz E, Golenbock DT, Coyle AJ, Liao SM, Maniatis T. 2003. Ikkepsilon and TBK1 are essential components of the IRF3 signaling pathway. Nat Immunol. 4(5):491–96.
   PubMed Web of Science ®Google Scholar
• Gack MU, Albrecht RA, Urano T, Inn KS, Huang IC, Carnero E, Farzan M, Inoue S, Jung JU, García-Sastre A. 2009. Influenza a virus NS1 targets the ubiquitin ligase TRIM25 to evade recognition by the host viral RNA sensor RIG-I. Cell Host Microbe. 5(5):439–49.
   PubMed Web of Science ®Google Scholar
• Gack MU, Kirchhofer A, Shin YC, Inn KS, Liang C, Cui S, Myong S, Ha T, Hopfner KP, Jung JU. 2008. Roles of RIG-I N-terminal tandem CARD and splice variant in TRIM25-mediated antiviral signal transduction. Proc Natl Acad Sci U S A. 105(43):16743–48.
   PubMed Web of Science ®Google Scholar
• Gack MU, Shin YC, Joo CH, Urano T, Liang C, Sun L, Takeuchi O, Akira S, Chen Z, Inoue S, et al. 2007. TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity. Nature. 446(7138):916–20.
   PubMed Web of Science ®Google Scholar
• Han G, Chen G, Shen B, Li Y. 2013. Tim-3: An activation marker and activation limiter of innate immune cells. Front Immunol. 4:449.
   PubMed Web of Science ®Google Scholar
• Hou H, Liu W, Wu S, Lu Y, Peng J, Zhu Y, Lu Y, Wang F, Sun Z. 2014. Tim-3 negatively mediates natural killer cell function in LPS-induced endotoxic shock. PloS One. 9(10):e110585.
   PubMed Web of Science ®Google Scholar
• Iuliano AD, Roguski KM, Chang HH, Muscatello DJ, Palekar R, Tempia S, Cohen C, Gran JM, Schanzer D, Cowling BJ, et al. 2018. Estimates of global seasonal influenza-associated respiratory mortality: A modelling study. Lancet. 391(10127):1285–300.
   PubMed Web of Science ®Google Scholar
• Jiang X, Chen ZJ. 2011. The role of ubiquitylation in immune defence and pathogen evasion. Nat Rev Immunol. 12(1):35–48.
   PubMed Web of Science ®Google Scholar
• Jiang X, Zhou T, Xiao Y, Yu J, Dou S, Chen G, Wang R, Xiao H, Hou C, Wang W, et al. 2016. Tim-3 promotes tumor-promoting M2 macrophage polarization by binding to STAT1 and suppressing the STAT1-miR-155 signaling axis. Oncoimmunology. 5(9):e1211219.
   PubMed Web of Science ®Google Scholar
• Ju Y, Hou N, Meng J, Wang X, Zhang X, Zhao D, Liu Y, Zhu F, Zhang L, Sun W, et al. 2010. T cell immunoglobulin- and mucin-domain-containing molecule-3 (Tim-3) mediates natural killer cell suppression in chronic hepatitis B. J Hepatol. 52(3):322–29.
   PubMed Web of Science ®Google Scholar
• Kanai Y, Satoh T, Igawa K, Yokozeki H. 2012. Impaired expression of Tim-3 on Th17 and Th1 cells in psoriasis. Acta Derm Venereol. 92(4):367–71.
   PubMed Web of Science ®Google Scholar
• Kato H, Takeuchi O, Sato S, Yoneyama M, Yamamoto M, Matsui K, Uematsu S, Jung A, Kawai T, Ishii KJ, et al. 2006. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature. 441(7089):101–05.
   PubMed Web of Science ®Google Scholar
• Kawai T, Akira S. 2011. Regulation of innate immune signalling pathways by the tripartite motif (TRIM) family proteins. EMBO Mol Med. 3(9):513–27.
   PubMed Web of Science ®Google Scholar
• Kuniyoshi K, Takeuchi O, Pandey S, Satoh T, Iwasaki H, Akira S, Kawai T. 2014. Pivotal role of RNA-binding E3 ubiquitin ligase MEX3C in RIG-I-mediated antiviral innate immunity. Proc Natl Acad Sci U S A. 111(15):5646–51.
   PubMed Web of Science ®Google Scholar
• Lee J, Su EW, Zhu C, Hainline S, Phuah J, Moroco JA, Smithgall TE, Kuchroo VK, Kane LP. 2011. Phosphotyrosine-Dependent coupling of Tim-3 to T-cell receptor signaling pathways. Mol Cell Biol. 31(19):3963–74.
   PubMed Web of Science ®Google Scholar
• Leitner J, Rieger A, Pickl WF, Zlabinger G, Grabmeier-Pfistershammer K, Steinberger P. 2013. TIM-3 does not act as a receptor for galectin-9. PLoS Pathog. 9(3):e1003253.
   PubMed Web of Science ®Google Scholar
• Li G, Hou C, Dou S, Zhang J, Zhang Y, Liu Y, Wang Z, Xiao H, Wang R, Chen G, et al. 2019. Monoclonal antibody against human Tim-3 enhances antiviral immune response. Scand J Immunol. 89(2):e12738.
   PubMed Web of Science ®Google Scholar
• Liu Y, Gordesky-Gold B, Leney-Greene M, Weinbren NL, Tudor M, Cherry S. 2018. Inflammation-Induced, STING-dependent autophagy restricts Zika virus infection in the drosophila brain. Cell Host Microbe. 24(1):57–68.e53.
   PubMed Web of Science ®Google Scholar
• Liu J, Qian C, Cao X. 2016. Post-Translational modification control of innate immunity. Immunity. 45(1):15–30.
   PubMed Web of Science ®Google Scholar
• Loo YM, Gale MsJr. 2011. Immune signaling by RIG-I-like receptors. Immunity. 34(5):680–92.
   PubMed Web of Science ®Google Scholar
• Luo R, Xiao S, Jiang Y, Jin H, Wang D, Liu M, Chen H, Fang L. 2008. Porcine reproductive and respiratory syndrome virus (PRRSV) suppresses interferon-beta production by interfering with the RIG-I signaling pathway. Mol Immunol. 45(10):2839–46.
   PubMed Web of Science ®Google Scholar
• Medvedev AE, Murphy M, Zhou H, Li X. 2015. E3 ubiquitin ligases Pellinos as regulators of pattern recognition receptor signaling and immune responses. Immunol Rev. 266(1):109–22.
   PubMed Web of Science ®Google Scholar
• Ocana-Guzman R, Torre-Bouscoulet L, Sada-Ovalle I. 2016. TIM-3 regulates distinct functions in macrophages. Front Immunol. 7:229.
   PubMed Web of Science ®Google Scholar
• Oshiumi H, Matsumoto M, Seya T. 2012. Ubiquitin-Mediated modulation of the cytoplasmic viral RNA sensor RIG-I. J Biochem. 151(1):5–11.
   PubMed Web of Science ®Google Scholar
• Oshiumi H, Miyashita M, Inoue N, Okabe M, Matsumoto M, Seya T. 2010. The ubiquitin ligase Riplet is essential for RIG-I-dependent innate immune responses to RNA virus infection. Cell Host Microbe. 8(6):496–509.
   PubMed Web of Science ®Google Scholar
• Rajsbaum R, Albrecht RA, Wang MK, Maharaj NP, Versteeg GA, Nistal-Villán E, García-Sastre A, Gack MU. 2012. Species-Specific inhibition of RIG-I ubiquitination and IFN induction by the influenza a virus NS1 protein. PLoS Pathog. 8(11):e1003059.
   PubMed Web of Science ®Google Scholar
• Saito T, Hirai R, Loo YM, Owen D, Johnson CL, Sinha SC, Akira S, Fujita T, Gale MsJr. 2007. Regulation of innate antiviral defenses through a shared repressor domain in RIG-I and LGP2. Proc Natl Acad Sci U S A. 104(2):582–87.
   PubMed Web of Science ®Google Scholar
• Sanchez-Fueyo A, Tian J, Picarella D, Domenig C, Zheng XX, Sabatos CA, Manlongat N, Bender O, Kamradt T, Kuchroo VK, et al. 2003. Tim-3 inhibits T helper type 1-mediated auto- and alloimmune responses and promotes immunological tolerance. Nat Immunol. 4(11):1093–101.
   PubMed Web of Science ®Google Scholar
• Seth RB, Sun L, Ea CK, Chen ZJ. 2005. Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF3. Cell. 122(5):669–82.
   PubMed Web of Science ®Google Scholar
• Song Y, Lai L, Chong Z, He J, Zhang Y, Xue Y, Xie Y, Chen S, Dong P, Chen L, et al. 2017. E3 ligase FBXW7 is critical for RIG-I stabilization during antiviral responses. Nat Commun. 8:14654.
   PubMed Web of Science ®Google Scholar
• Sui L, Zhang W, Chen Y, Zheng Y, Wan T, Zhang W, Yang Y, Fang G, Mao J, Cao X. 2006. Human membrane protein Tim-3 facilitates hepatitis a virus entry into target cells. Int J Mol Med. 17(6):1093–99.
   PubMed Web of Science ®Google Scholar
• Takeuchi O, Akira S. 2009. Innate immunity to virus infection. Immunol Rev. 227(1):75–86.
   PubMed Web of Science ®Google Scholar
• Tenoever BR, Ng SL, Chua MA, McWhirter SM, García-Sastre A, Maniatis T. 2007. Multiple functions of the IKK-related kinase IKKepsilon in interferon-mediated antiviral immunity. Science. 315(5816):1274–78.
   PubMed Web of Science ®Google Scholar
• Tomkowicz B, Walsh E, Cotty A, Verona R, Sabins N, Kaplan F, Santulli-Marotto S, Chin CN, Mooney J, Lingham RB, et al. 2015. TIM-3 suppresses anti-CD3/CD28-Induced TCR activation and IL-2 expression through the NFAT signaling pathway. PloS One. 10(10):e0140694.
   PubMed Web of Science ®Google Scholar
• Wang W, Jiang M, Liu S, Zhang S, Liu W, Ma Y, Zhang L, Zhang J, Cao X. 2016. RNF122 suppresses antiviral type I interferon production by targeting RIG-I CARDs to mediate RIG-I degradation. Proc Natl Acad Sci U S A. 113(34):9581–86.
   PubMed Web of Science ®Google Scholar
• Wang Z, Li G, Dou S, Zhang Y, Liu Y, Zhang J, Li G, Hou C, Wang R, Shen B, et al. 2020. Tim-3 promotes listeria monocytogenes immune evasion by suppressing major histocompatibility complex class I. J Infect Dis. 221(5):830–40.
   PubMed Web of Science ®Google Scholar
• Wang Z, Sun D, Chen G, Li G, Dou S, Wang R, Xiao H, Hou C, Li Y, Feng J, et al. 2017. Tim-3 inhibits macrophage control of Listeria monocytogenes by inhibiting Nrf2. Sci Rep. 7:42095.
   PubMed Web of Science ®Google Scholar
• Wu SF, Xia L, Shi XD, Dai YJ, Zhang WN, Zhao JM, Zhang W, Weng XQ, Lu J, Le HY, et al. 2020. RIG-I regulates myeloid differentiation by promoting TRIM25-mediated ISGylation. Proc Natl Acad Sci U S A. 117(25):14395–404.
   PubMed Web of Science ®Google Scholar
• Yang X, Jiang X, Chen G, Xiao Y, Geng S, Kang C, Zhou T, Li Y, Guo X, Xiao H, et al. 2013. T cell Ig mucin-3 promotes homeostasis of sepsis by negatively regulating the TLR response. J Immunol. 190(5):2068–79.
   PubMed Web of Science ®Google Scholar
• Zhang J, Hou C, Dou S, Li G, Wang Z, Liu Y, Zhang Y, Wang R, Shen B, Han G. 2021. T cell immunoglobulin and mucin domain protein 3 inhibits glycolysis in RAW 264.7 macrophages through Hexokinase 2. Scand J Immunol. 93(2):e12981.
   PubMed Web of Science ®Google Scholar
• Zhao Z, Jiang X, Kang C, Xiao Y, Hou C, Yu J, Wang R, Xiao H, Zhou T, Wen Z, et al. 2014. Blockade of the T cell immunoglobulin and mucin domain protein 3 pathway exacerbates sepsis-induced immune deviation and immunosuppression. Clin Exp Immunol. 178(2):279–91.
   PubMed Web of Science ®Google Scholar
• Zhao K, Zhang Q, Li X, Zhao D, Liu Y, Shen Q, Yang M, Wang C, Li N, Cao X. 2016. Cytoplasmic STAT4 promotes antiviral type I IFN production by blocking CHIP-mediated degradation of RIG-I. J Immunol. 196(3):1209–17.
   PubMed Web of Science ®Google Scholar